Neyssa Marina
Publication Details
-
Comparison of cytokines in children with recurrent solid tumors treated with intensive chemotherapy.
J Pediatr Hematol Oncol. 1998 Jan-Feb; (1): 62-8
To compare the relative hematopoietic protective effects of recombinant human interleukin-1alpha (rhuIL-1alpha), recombinant human granulocyte macrophage colony-stimulating factor (rhuGM-CSF), and PIXY321, a genetically engineered fusion protein combining interleukin-3 and rhuGM-CSF, in children with refractory solid tumors after treatment with ifosfamide, carboplatin, and etoposide (ICE).

